137 related articles for article (PubMed ID: 3599021)
1. C3-methylated 5-hydroxy-2-(dipropylamino)tetralins: conformational and steric parameters of importance for central dopamine receptor activation.
Johansson AM; Nilsson JL; Karlén A; Hacksell U; Svensson K; Carlsson A; Kenne L; Sundell S
J Med Chem; 1987 Jul; 30(7):1135-44. PubMed ID: 3599021
[TBL] [Abstract][Full Text] [Related]
2. C1- and C3-methyl-substituted derivatives of 7-hydroxy-2-(di-n-propylamino)tetralin: activities at central dopamine receptors.
Johansson AM; Nilsson JL; Karlén A; Hacksell U; Sanchez D; Svensson K; Hjorth S; Carlsson A; Sundell S; Kenne L
J Med Chem; 1987 Oct; 30(10):1827-37. PubMed ID: 3656358
[TBL] [Abstract][Full Text] [Related]
3. Central dopaminergic and 5-hydroxytryptaminergic effects of C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin.
Mellin C; Björk L; Karlén A; Johansson AM; Sundell S; Kenne L; Nelson DL; Andén NE; Hacksell U
J Med Chem; 1988 Jun; 31(6):1130-40. PubMed ID: 2967376
[TBL] [Abstract][Full Text] [Related]
4. C1-Methylated 5-hydroxy-2-(dipropylamino)tetralins: central dopamine-receptor stimulating activity.
Hacksell U; Johansson AM; Arvidsson L; Nilsson JL; Hjorth S; Carlsson A; Wikström H; Sanchez D; Lindberg P
J Med Chem; 1984 Aug; 27(8):1003-7. PubMed ID: 6431102
[TBL] [Abstract][Full Text] [Related]
5. (+)-cis-8-Hydroxy-1-methyl-2-(di-n-propylamino)tetralin: a potent and highly stereoselective 5-hydroxytryptamine receptor agonist.
Arvidsson LE; Johansson AM; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Magnusson T; Carlsson A; Andersson B; Wikström H
J Med Chem; 1987 Nov; 30(11):2105-9. PubMed ID: 2959776
[TBL] [Abstract][Full Text] [Related]
6. Structural factors of importance for 5-hydroxytryptaminergic activity. Conformational preferences and electrostatic potentials of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) and some related agents.
Arvidsson LE; Karlén A; Norinder U; Kenne L; Sundell S; Hacksell U
J Med Chem; 1988 Jan; 31(1):212-21. PubMed ID: 2961887
[TBL] [Abstract][Full Text] [Related]
7. Conformational analysis of the dopamine-receptor agonist 5-hydroxy-2-(dipropylamino)tetralin and its C(2)-methyl-substituted derivative.
Karlén A; Johansson AM; Kenne L; Arvidsson LE; Hacksell U
J Med Chem; 1986 Jun; 29(6):917-24. PubMed ID: 3712382
[TBL] [Abstract][Full Text] [Related]
8. Resolved cis- and trans-2-amino-5-methoxy-1-methyltetralins: central dopamine receptor agonists and antagonists.
Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Carlsson A
J Med Chem; 1987 Apr; 30(4):602-11. PubMed ID: 3560156
[TBL] [Abstract][Full Text] [Related]
9. 8-Hydroxy-2-(alkylamino)tetralins and related compounds as central 5-hydroxytryptamine receptor agonists.
Arvidsson LE; Hacksell U; Johansson AM; Nilsson JL; Lindberg P; Sanchez D; Wikström H; Svensson K; Hjorth S; Carlsson A
J Med Chem; 1984 Jan; 27(1):45-51. PubMed ID: 6418888
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic 2-aminotetralins: affinities for dopamine D2-receptors, molecular structures, and conformational preferences.
Johansson AM; Karlén A; Grol CJ; Sundell S; Kenne L; Hacksell U
Mol Pharmacol; 1986 Sep; 30(3):258-69. PubMed ID: 2943981
[TBL] [Abstract][Full Text] [Related]
11. Novel dopamine receptor agonists and antagonists with preferential action on autoreceptors.
Johansson AM; Arvidsson LE; Hacksell U; Nilsson JL; Svensson K; Hjorth S; Clark D; Carlsson A; Sanchez D; Andersson B
J Med Chem; 1985 Aug; 28(8):1049-53. PubMed ID: 3927002
[TBL] [Abstract][Full Text] [Related]
12. Further characterization of structural requirements for agonists at the striatal dopamine D2 receptor and a comparison with those at the striatal dopamine D1 receptor. Studies with a series of monohydroxyaminotetralins on acetylcholine release from rat striatum.
Seiler MP; Markstein R
Mol Pharmacol; 1984 Nov; 26(3):452-7. PubMed ID: 6238231
[TBL] [Abstract][Full Text] [Related]
13. A C2-methylated derivative of the 5-hydroxy-tryptamine-receptor agonist 8-hydroxy-2-(dipropylamino)tetralin (8-OH DPAT).
Mellin C; Liu Y; Hacksell U; Björk L; Andén NE
Acta Pharm Suec; 1987; 24(4):153-60. PubMed ID: 2964167
[No Abstract] [Full Text] [Related]
14. Resolved N,N-dialkylated 2-amino-8-hydroxytetralins: stereoselective interactions with 5-HT1A receptors in the brain.
Björk L; Höök BB; Nelson DL; Andén NE; Hacksell U
J Med Chem; 1989 Apr; 32(4):779-83. PubMed ID: 2522991
[TBL] [Abstract][Full Text] [Related]
15. (R)- and (S)-5-hydroxy-2-(dipropylamino)tetralin (5-OH DPAT): assessment of optical purities and dopaminergic activities.
Karlsson A; Björk L; Pettersson C; Andén NE; Hacksell U
Chirality; 1990; 2(2):90-5. PubMed ID: 1976017
[TBL] [Abstract][Full Text] [Related]
16. A 3-D model for 5-HT1A-receptor agonists based on stereoselective methyl-substituted and conformationally restricted analogues of 8-hydroxy-2-(dipropylamino)tetralin.
Mellin C; Vallgårda J; Nelson DL; Björk L; Yu H; Andén NE; Csöregh I; Arvidsson LE; Hacksell U
J Med Chem; 1991 Feb; 34(2):497-510. PubMed ID: 1995871
[TBL] [Abstract][Full Text] [Related]
17. (R)- and (S)-5,6,7,8-tetrahydro-1-hydroxy-N,N-dipropyl-9H-benzocyclohepten- 8-ylamine. Stereoselective interactions with 5-HT1A receptors in the brain.
Liu Y; Mellin C; Björk L; Svensson B; Csöregh I; Helander A; Kenne L; Andén NE; Hacksell U
J Med Chem; 1989 Oct; 32(10):2311-8. PubMed ID: 2795604
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and pharmacology of the enantiomers of cis-7-hydroxy-3-methyl-2-(dipropylamino)tetralin.
Johansson AM; Fredriksson K; Hacksell U; Grol CJ; Svensson K; Carlsson A; Sundell S
J Med Chem; 1990 Oct; 33(10):2925-9. PubMed ID: 2120444
[TBL] [Abstract][Full Text] [Related]
19. Effects of the C3-methylated derivatives of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) on central 5-hydroxytryptamine receptors.
Björk L; Mellin C; Hacksell U; Andén NE
Eur J Pharmacol; 1987 Nov; 143(1):55-63. PubMed ID: 2961582
[TBL] [Abstract][Full Text] [Related]
20. Structure-activity relationships of dopaminergic 5-hydroxy-2-aminotetralin derivatives with functionalized N-alkyl substituents.
Seiler MP; Stoll AP; Closse A; Frick W; Jaton A; Vigouret JM
J Med Chem; 1986 Jun; 29(6):912-7. PubMed ID: 3712381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
